-
-
Humanized model of the immune system
-
iHuPBMC-T
-
iHuPBMC-NK
-
iHuPBMC-B
-
PBMC-LT
-
CD34+ HSC
-
Winn model
-
iHuPBMC-MHC/KO
-
iHuPBMC-OncVax
-
PBMC mixed inoculation model
more -
-
In vivo tumor experimental platform
-
CDX
-
iHuPDX
-
Non-GLP Toxicology
-
PK/PD
-
Brain in situ model
-
Other in situ models
-
Hematologic tumor model system inoculation
-
Creation of high interstitial tumor models
more -
-
In vitro killing experiment platform
-
Immune co-culture killing model
-
CDC
-
In vitro killing experiment platform
-
IC50
-
PDC High-Throughput In Vitro Pharmacodynamics
-
3D organoids
-
ADCC
-
T cell-mediated killing experiment
more -
-
Mouse-derived immune system model
more -
Tumor vaccine
more -
Cell therapy
more -
In vitro testing platform
more -
Non-GLP Toxicology Platform
more -
Non-tumor model and drug efficacy evaluation platform
-
Systematic Vaccination Model
-
Non-tumor model and drug efficacy evaluation platform
-
Skin injury model
-
Stroke model
-
Liver fibrosis model
-
Diabetes model
-
Gouty Arthritis (GA) Model
-
Pulmonary fibrosis model
-
Systemic lupus erythematosus (SLE) model
-
Inflammatory Bowel Disease (IBD) model
-
Rheumatoid Arthritis (RA) Model
more -
-
-
-
PDX model
-
PDX model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Human breast cancer
-
Esophageal cancer in humans
-
Human gastric cancer
-
Colorectal cancer
-
Human liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Human pancreatic cancer
-
Human kidney cancer
-
Human Bladder Cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer in women
-
Human Ovarian Cancer
-
Human skin cancer
-
sarcoma
-
Human Nervous System Cancer
-
Embryonal carcinoma
-
Human Lymphoma
-
Human leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other people
more -
-
CDX model
-
CDX model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Human breast cancer
-
Esophageal cancer in humans
-
Human gastric cancer
-
Colorectal cancer
-
Human liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Human pancreatic cancer
-
Human kidney cancer
-
Human Bladder Cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer in women
-
Human Ovarian Cancer
-
Human skin cancer
-
sarcoma
-
Human Nervous System Cancer
-
Embryonal carcinoma
-
Human Lymphoma
-
Human leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other people
more -
-
Homogeneous Model
-
Homogeneous Model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Breast cancer
-
Stomach cancer
-
Liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Pancreatic cancer
-
Kidney cancer
-
Bladder cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer
-
Ovarian cancer
-
Esophageal cancer
-
Skin cancer
-
sarcoma
-
Nervous System Cancer
-
Embryonal carcinoma
-
Lymphoma
-
Leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other
-
Colorectal cancer
more -
-
News Center
——
InnoModels Biotechnology: Immunoco-culture killing model features introduction
Author:
InnoModels Biotechnology
Release time:
2024-02-05
InnoModels Biotechnology has been actively exploring and promoting innovation in the field of biotechnology, and its Immunoco-culture Kill Model is undoubtedly an important technological achievement that the company is proud of. The application of this model in the field of immune research provides scientists with an unprecedented opportunity to gain an in-depth understanding of the complexity of the immune system and the potential for anti-tumor therapy.
Highly reproducible in vivo immune microenvironment
InnoModels's immune co-culture killing model stands out for its high degree of reproduction of the in vivo immune microenvironment. By simulating the process of immune cell interactions in vivo, the model provides researchers with a more realistic and reliable experimental platform. This enables scientists to more accurately assess the effects of drug candidates in the immune system, providing a solid foundation for the development of novel therapeutic approaches.
Multi-dimensional immune cell evaluation
InnoModels's immune co-culture killing model not only restores the in vivo immune microenvironment, but also supports multi-dimensional immune cell assessment. Researchers can simultaneously examine the activity and interactions of multiple immune cell types, including T cells, B cells, macrophages, etc., to gain a more comprehensive understanding of the overall dynamics of the immune system. This provides critical data for a deeper understanding of the mechanisms of immunotherapy.

Application to anti-cancer therapy research
The immune co-culture killing model has great potential in anti-cancer therapy research. Through this model, researchers are able to assess the killing effect of immune cells on tumor cells, providing strong support for personalized anti-cancer therapy. This simulation of immune cell-tumor cell interactions can help discover new targets and drugs, and promote the innovative development of anticancer therapies.
Innovative data analysis and reporting tools
InnoModels Biotechnology focuses on providing users with innovative data analysis and reporting tools. The massive amount of data generated by the immune co-culture killing model can be interpreted by advanced analysis tools, providing researchers with a clear and intuitive presentation of experimental results. This innovative data analysis supports researchers to better understand the dynamics of the immune system, thus guiding drug development and optimization of therapeutic strategies.
Continuous Technology Upgrade and Service Support
InnoModels Biotechnology has been committed to the technological upgrading of immune co-culture killing models. By introducing new technologies and methods, the company ensures that its models remain at the forefront of science and technology. In addition, the company provides a full range of technical support and services to ensure that researchers are able to take full advantage of the immunoco-culture killing models for their scientific studies.
Summary
With its highly reproducible in vivo immune microenvironment, multi-dimensional immune cell assessment, application to anti-cancer therapeutic research, innovative data analysis and reporting tools, as well as continuous technological upgrades and service support, the Immunoculture Co-Culture Killing Model of InnoModels Biotechnology has become a leading tool in the field of immunology research. The features of this model not only provide researchers with an advanced experimental platform, but also inject new vitality into the research and development of the immunotherapy field.
InnoModels Biotechnology (Beijing) Co., Ltd.
-
TEL: +86 15711355061
-
E-mail: xuyl@imodels.tech
-
Address: Building 14, No. 79 West Shuangying Road, Changping District, Beijing
COOKIES
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
COOKIES
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.
These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.
These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.
These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.
InnoModels Biotechnology (Beijing) Co., Ltd